Yibin Liu Selected Research

Yibin Liu Research Topics

Disease

14	Neoplasms (Cancer) 09/2022 - 01/2016
3	Adenocarcinoma 08/2022 - 05/2019
3	Hypoxia (Hypoxemia) 01/2022 - 01/2018
2	Hepatocellular Carcinoma (Hepatoma) 09/2021 - 01/2021
2	Osteoarthritis 01/2021 - 01/2019
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 01/2018
2	Neoplasm Metastasis (Metastasis) 10/2018 - 03/2017
1	Hemorrhage 04/2022
1	Allergic Rhinitis 02/2022
1	COVID-19 02/2022
1	Autoimmune Diseases of the Nervous System 01/2022
1	Ovarian Teratoma 01/2022
1	Encephalitis (Encephalitis, Rasmussen) 01/2022
1	Teratoma (Teratoid Tumor) 01/2022
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2022
1	Fetal Hypoxia 11/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 11/2021
1	Obstructive Sleep Apnea 01/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021
1	Starvation 12/2020
1	Arthritis (Polyarthritis) 10/2020
1	Inflammation (Inflammations) 10/2020
1	Chondrosarcoma 04/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2018
1	Brain Edema (Cerebral Edema) 01/2018
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2018
1	Acute Kidney Injury (Acute Renal Failure) 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Communicable Diseases (Infectious Diseases) 11/2016
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Spasm (Spasms) 02/2014
1	Congenital Abnormalities (Deformity) 02/2014
1	Contracture 02/2014
1	Hyperemia 08/2012
1	Infections 05/2009

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 08/2022 - 01/2018
3	Cell-Free Nucleic AcidsIBA 09/2021 - 11/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 11/2016
2	Biological ProductsIBA 10/2021 - 11/2016
2	safranine T (safranin)IBA 01/2021 - 01/2019
2	Chimeric Antigen ReceptorsIBA 01/2021 - 05/2019
2	EnzymesIBA 12/2020 - 01/2017
2	Sirolimus (Rapamycin)FDA Link 10/2020 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 10/2018 - 01/2017
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2022
1	Photosensitizing Agents (Photosensitizers)IBA 04/2022
1	TubulinIBA 04/2022
1	AQ4NIBA 01/2022
1	Circular RNAIBA 01/2022
1	AntibodiesIBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	SteroidsIBA 01/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022
1	N-Methylaspartate (NMDA)IBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022
1	Oxygen (Dioxygen)IBA 11/2021
1	Carbonic Anhydrase IIIIBA 11/2021
1	Messenger RNA (mRNA)IBA 11/2021
1	morusinIBA 10/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021
1	MetalsIBA 10/2021
1	artenimol (dihydroartemisinin)IBA 01/2021
1	ibrutinibIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 12/2020
1	InterleukinsIBA 04/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2019
1	ProdrugsIBA 05/2019
1	MicroRNAs (MicroRNA)IBA 05/2019
1	Fast GreenIBA 01/2019
1	CateninsIBA 01/2019
1	Lipoprotein(a)IBA 01/2019
1	DisintegrinsIBA 10/2018
1	ThrombospondinsIBA 10/2018
1	Metalloproteases (Metalloproteinases)IBA 10/2018
1	CaspasesIBA 01/2018
1	Sevoflurane (Ultane)FDA LinkGeneric 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	Small Interfering RNA (siRNA)IBA 03/2017
1	AvidinIBA 01/2017
1	Antimitotic AgentsIBA 01/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2016
1	AntioxidantsIBA 08/2012
1	Pharmaceutical PreparationsIBA 05/2009

Therapy/Procedure

8	Therapeutics 09/2022 - 03/2017
3	Immunotherapy 02/2022 - 05/2019
2	Photochemotherapy (Photodynamic Therapy) 09/2022 - 04/2022
2	Intravenous Administration 04/2022 - 01/2022
1	Drug Therapy (Chemotherapy) 04/2022
1	Treatment Delay 02/2022
1	Plasma Exchange 01/2022
1	Continuous Positive Airway Pressure 01/2021
1	Radiofrequency Ablation 01/2021
1	Organ Transplantation 11/2016
1	Orthopedic Procedures 02/2014
1	Tenotomy 02/2014
1	Endarterectomy (Thromboendarterectomy) 02/2014
1	Oral Administration 05/2009